Drug Type Synthetic peptide |
Synonyms- |
Target |
Action inhibitors |
Mechanism HDAC inhibitors(Histone deacetylase inhibitors), Epigenetic drug |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Molecular FormulaC34H49N5O6 |
InChIKeyJWOGUUIOCYMBPV-GMFLJSBRSA-N |
CAS Registry183506-66-3 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Parasitic Diseases | Preclinical | United States | 12 Nov 1996 |